Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary results

Hakmook Kang; Allison Hainline; Lori R. Arlinghaus; Stephanie Elderidge; Xia Li; Vandana G. Abramson; Anuradha Bapsi Chakravarthy; Richard G. Abramson; Brian Bingham; Kareem Fakhoury; Thomas E. Yankeelov

doi:10.1117/1.JMI.5.1.011015

29 December 2017 Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary results

Hakmook Kang, Allison Hainline, Lori R. Arlinghaus, Stephanie Elderidge, Xia Li, Vandana G. Abramson, Anuradha Bapsi Chakravarthy, Richard G. Abramson, Brian Bingham, Kareem Fakhoury, Thomas E. Yankeelov

Author Affiliations +

Journal of Medical Imaging, Vol. 5, Issue 1, 011015 (December 2017). https://doi.org/10.1117/1.JMI.5.1.011015

Abstract

Pathologic complete response following neoadjuvant therapy (NAT) is used as a short-term surrogate marker of eventual outcome in patients with breast cancer. Analyzing voxel-level heterogeneity in MRI-derived parametric maps, obtained before and after the first cycle of NAT (n=33), in conjunction with receptor status, may improve the predictive accuracy of tumor response to NAT. Toward that end, we incorporated two MRI-derived parameters, the apparent diffusion coefficient and efflux rate constant, with receptor status in a logistic ridge-regression model. The area under the curve (AUC) and Brier score of the model computed via 10-fold cross validation were 0.94 (95% CI: 0.85, 0.99) and 0.11 (95% CI: 0.06, 0.16), respectively. These two statistics strongly support the hypothesis that our proposed model outperforms the other models that we investigated (namely, models without either receptor information or voxel-level information). The contribution of the receptor information was manifested by an 8% to 15% increase in AUC and a 14% to 21% decrease in Brier score. These data indicate that combining multiparametric MRI with hormone receptor status has a high likelihood of improved prediction of pathologic response to NAT in breast cancer.

Citation Download Citation

Hakmook Kang, Allison Hainline, Lori R. Arlinghaus, Stephanie Elderidge, Xia Li, Vandana G. Abramson, Anuradha Bapsi Chakravarthy, Richard G. Abramson, Brian Bingham, Kareem Fakhoury, and Thomas E. Yankeelov "Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary results," Journal of Medical Imaging 5(1), 011015 (29 December 2017). https://doi.org/10.1117/1.JMI.5.1.011015

Received: 30 June 2017; Accepted: 5 December 2017; Published: 29 December 2017

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available